In Hubei Province, China, where the ‘new’ virus was first diagnosed, and where the vast majority of the cases have occurred, it’s no longer considered necessary to test for the presence of CV antibodies before diagnosing the disease.
Let’s say that again.
The epicentre of the so-called new virus outbreak is currently diagnosing new cases of the disease without testing for the virus.
Instead they are relying on ‘clinical diagnosis’, which is defined as [our emphasis]:
The estimated identification of the disease underlying a patient’s complaints based merely on signs, symptoms and medical history of the patient rather than on laboratory examination or medical imaging.
Which means physicians look at presenting symptoms and make a guess on what is causing them.
Now if you’re talking about something like Smallpox that option can make some sense – because Smallpox presents with one very distinct clinical feature – a recognisable rash – that makes it fairly easy to distinguish from other viral agents or other disease processes.
But the ‘new’ coronavirus does not do that. In fact, symptoms of the ‘new’ CV are exactly like symptoms of the numerous ‘old’ CVs, and indeed of the common cold or flu. Cough, fever, malaise, upper respiratory tract inflammation and (in severe cases) lung involvement – up to and including full-blown pneumonia.
The only way to differentiate a case of ‘new’ CV from severe regular flu, viral pneumonia or even environmental lung disease, is by testing for antibodies. If they aren’t doing this, physicians in Hubei Province are now at grave risk of essentially diagnosing every single case of pneumonia or lung inflammation they see as the new CV.’